Efficacy of oral iron supplementation is not enhanced by additional intravenous iron during autologous blood donation

Transfusion

Volumn 38, Issue 8, 1998, Pages 764-770

  Kasper, S M ^a   Lazansky, H ^a   Stark, C ^a   Klimek, M ^a   Laubinger, R ^a   Borner U ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; IRON; PLACEBO;

ADULT; ANEMIA; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRON DEFICIENCY; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS;

EID: 0031852115     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.38898375516.x     Document Type: Article

References (27)

1. Kruskall MS, Glazer EE, Leonard SS, et al. Utilization and effectiveness of a hospital autologous preoperative blood donor program. Transfusion 1986;26:335-40.
2. Goodnough LT, Wasman J, Corlucci K, Chernosky A. Limitations to donating adequate autolgous blood prior to electivce orthopedic surgery. Arch Surg 1989;124:494-6.
3. Kickler TS, Spivak JL. Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors. JAMA 1988;260:65-7.
4. Goodnough LT, Brittenham GM. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J Lab Clin Med 1990;115:28-35.
5. Finch S, Haskins D, Finch CA. Iron metabolism. Hematopoiesis following phlebotomy. Iron as a limiting factor. J Clin Invest 1950;29:1078-86.
6. Biesma DH, Kraaijenhagen RJ, Poortman J, et al. The effect of oral iron supplementation on erythropoiesis in autologous blood donors. Transfusion 1992;32:162-5.
7. Strauss RG. Iron for autologous blood donors needs more work (letter). Transfusion 1992;32:788-9.
8. National Heart, Lung, and Blood Institute Expert Panel on the Use of Autologous Blood. Transfusion alert: use of autologous blood. Transfusion 1995;35:703-11.
9. Weisbach V, Eckstein R. [Iron homeostasis in preoperative autologous blood donation] (Engl abstract). Infusionsther Transfusionsmed 1996;23:161-70.
10. Mercuriali F, Zanella A, Barosi G, et al. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993;33:55-60.
11. Von Bormann B, Aulich S. Autologe Transfusionsverfahren: Nutzen und Risiko. Dtsch Ärzteblatt 1993;90:A1-2912-8.
12. Walpoth BH, Schwaller J, Hofstetter H, et al. Current problems with autologous blood supply. Infusionsther Transfusionsmed 1993;20:316-26.
13. Schulte-Tamburen AM, Tryba M, Rost F, Zenz M. High dose intravenous iron supplementation facilitates autologous blood donation (abstract). Br J Anaesth 1994;72(Suppl 1):23.
14. Schindler E, Scholz S, Boldt J, et al. [Effectiveness of oral versus parenteral iron substitution of iron in patients undergoing autologous blood donation] (Engl abstract). Infusionsther Transfusionsmed 1994;21:236-41.
15. The National Blood Resource Education Program Expert Panel. The use of autologous blood. JAMA 1990;263:414-7.
16. Klein HG, ed. Standards for blood banks and transfusion services. 17th ed. Arlington: American Association of Blood Banks, 1996:43-7.
17. Nadler SB, Hidalgo JU, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962;51:224-32.
18. Kasper SM, Gerlich W, Buzello W. Preoperative red cell production in patients undergoing weekly autologous blood donation. Transfusion 1997;37:1058-62.
19. Chaplin H Jr, Mollison PL, Vetter H. The body/venous hematocrit ratio: its constancy over a wide hematocrit range. J Clin Invest 1953;32:1309-16.
20. Henry JB, ed. Clinical diagnosis and management by laboratory methods. 17th ed. Philadelphia: Saunders, 1984.
21. Thomas L, ed. Labor und Diagnose. 4th ed. Marburg, Germany: Medizinische Verlagsgesellschaft, 1992.
22. Cook JD, Skikne BS, Lynch SR, Reusser ME. Estimates of iron sufficiency in the US population. Blood 1986;68:726-31.
23. Kasper SM, Gerlich W, Lynch J, Börner U. Intravenöse Eisensubstitution bei der präoperativen Eigenblutspende (abstract). Anaesthesist 1994;43(Suppl 1):138.
24. Lichner S, Fleischer F, Messmer K. Bietet die supportive intravenöse Eisendextrangabe bei der akuten präoperativen Eigenblutspende Vorteile? In: Mempel W, Mempel M, Heim MU, Schwarzfischer G, eds. Eigenbluttransfusion - eine aktuelle Übersicht. Munich: Sympomed, 1993:179-84.
25. National Heart, Lung, and Blood Institute Autologous Transfusion Symposium Working Group. Autologous transfusion: current trends and research issues. Transfusion 1995;35:525-31.
26. Skikne BS, Cook JD. Effect of enhanced erythropoiesis on iron absorption. J Lab Clin Med 1992;120:746-51.
27. Hillman RS, Finch CA. Drugs effective in iron-deficiency and other hypochromic anemias. In: Goodman Gilman A, Goodman LS, Rall TW, Murad F, eds. The pharmacological basis of therapeutics. 7th ed. New York: Macmillan Publishing Company, 1985:1308-22.